{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-086129","form_type":"8-K","ticker":"GLUE","cik":"0001826457","company_name":"Monte Rosa Therapeutics, Inc.","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.963779+00:00","generated_at":"2026-05-19T08:58:02.181875+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Monte Rosa Therapeutics elects three Class I directors, ratifies auditor at 2025 annual meeting","bullets":["Elected Christine Siu, Kimberly Blackwell, and Jan Skvarka as Class I directors for three-year terms ending in 2028.","Christine Siu received 52.1M for, 3.4M withheld; Jan Skvarka received 44.8M for, 10.7M withheld.","Ratified Deloitte & Touche LLP as independent auditor for FY 2025 with 57.9M for, 139k against, 12.9k abstain.","Record date April 16, 2025; 61,509,821 shares outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-086129","json":"https://secwatch.observer/filing/0000950170-25-086129.json","markdown":"https://secwatch.observer/filing/0000950170-25-086129.md","text":"https://secwatch.observer/filing/0000950170-25-086129.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826457/000095017025086129/0000950170-25-086129-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826457/000095017025086129/glue-20250613.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T08:58:02.181875+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}